Nano-X Imaging (NNOX) Stock Price, News & Analysis

Company Overview

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

Key Stats

• Today's Range: $6.49 to $6.92
• 50-Day Range: $5.66 to $8.38
• 52-Week Range: $5.26 to $14.28
• Volume: 2.14 million shs
• Average Volume: 2.00 million shs
• Market Capitalization: $390.59 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $12.00
• Consensus Rating: Buy

Nano-X Imaging Stock Analysis - MarketRank™

Nano-X Imaging scored higher than 47% of companies evaluated by MarketBeat, and ranked 214th out of 330 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Nano-X Imaging has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Nano-X Imaging has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Nano-X Imaging are expected to grow in the coming year, from ($0.92) to ($0.62) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Nano-X Imaging is -7.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nano-X Imaging is -7.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Nano-X Imaging has a P/B Ratio of 1.90. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

11.72% of the outstanding shares of Nano-X Imaging have been sold short.

Short Interest Ratio / Days to Cover

Nano-X Imaging has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nano-X Imaging has recently decreased by 7.39%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Nano-X Imaging does not currently pay a dividend.

Dividend Growth

Nano-X Imaging does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

11.72% of the outstanding shares of Nano-X Imaging have been sold short.

Short Interest Ratio / Days to Cover

Nano-X Imaging has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nano-X Imaging has recently decreased by 7.39%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: N/A

News Sentiment

Nano-X Imaging has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Business Services companies.

Search Interest

40 people have searched for NNOX on MarketBeat in the last 30 days. This is an increase of 167% compared to the previous 30 days.

MarketBeat Follows

12 people have added Nano-X Imaging to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Nano-X Imaging insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 7.74% of the stock of Nano-X Imaging is held by insiders.

Percentage Held by Institutions

Only 21.49% of the stock of Nano-X Imaging is held by institutions.

NNOX Stock Analysis - Frequently Asked Questions

How have NNOX shares performed this year?

Nano-X Imaging's stock was trading at $6.37 at the beginning of 2024. Since then, NNOX stock has increased by 6.1% and is now trading at $6.76.
View the best growth stocks for 2024 here.

How were Nano-X Imaging's earnings last quarter?

Nano-X Imaging Ltd. (NASDAQ:NNOX) issued its earnings results on Tuesday, August, 20th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.22) by $0.01. The business had revenue of $2.70 million for the quarter. Nano-X Imaging had a negative net margin of 465.38% and a negative trailing twelve-month return on equity of 27.63%.

When did Nano-X Imaging IPO?

Nano-X Imaging (NNOX) raised $100 million in an IPO on Friday, August 21st 2020. The company issued 5,900,000 shares at $16.00-$18.00 per share. Cantor, Oppenheimer, Berenberg and CIBC Capital Markets served as the underwriters for the IPO and National Securities Corp. was co-manager.

Who are Nano-X Imaging's major shareholders?

Top institutional shareholders of Nano-X Imaging include State Street Corp (1.70%), Geode Capital Management LLC (1.17%), ARK Investment Management LLC (0.44%) and Griffin Asset Management Inc. (0.34%).

How do I buy shares of Nano-X Imaging?

Shares of NNOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Nano-X Imaging own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Nano-X Imaging investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), AST SpaceMobile (ASTS), NIO (NIO), Bakkt (BKKT) and Virgin Galactic (SPCE).

Company Calendar

• Last Earnings: 8/20/2024
• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: X - ray apparatus & tubes
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:NNOX
• CUSIP: N/A
• CIK: 1795251
• Web: www.nanox.vision
• Phone: 972-02-536-0360
• Fax: 972-02-544-5214
• Employees: 190
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $12.00
• High Stock Price Target: $12.00
• Low Stock Price Target: $12.00
• Potential Upside/Downside: +77.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.85)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-60,780,000.00
• Net Margins: -465.38%
• Pretax Margin: -468.60%
• Return on Equity: -27.63%
• Return on Assets: -24.72%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.64
• Quick Ratio: 4.56

Sales & Book Value

• Annual Sales: $9.90 million
• Price / Sales: 39.45
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.55 per share
• Price / Book: 1.90

Miscellaneous

• Outstanding Shares: 57,780,000
• Free Float: 53,307,000
• Market Cap: $390.59 million
• Optionable: Optionable
• Beta: 2.02